What Is The Current and Historic Market Size Analysis Of The Smart Inhalers Market?
The smart inhalers market has seen considerable growth due to a variety of factors.
• In recent times, the size of the smart inhalers market has experienced swift expansion. An increase from $1.65 billion in 2024 to $1.81 billion in 2025 is expected, marking a compound annual growth rate (CAGR) of 10.1%.
The strong growth in the past period is due to heightened commitment to medical adherence, an intensified focus on patient-centric healthcare, and a rising demand for connected healthcare devices.
What Are The Predictions for The Smart Inhalers Market in the Coming Years?
The smart inhalers market is expected to maintain its strong growth trajectory in upcoming years.
• Predictions for the smart inhaler market size suggest a swift expansion over the upcoming years. It is projected to accrue a value of $2.66 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%.
Several factors are set to drive expansion during the forecasted period, including a surge in chronic respiratory diseases (CRDs), an amplified interest in home healthcare, and the wide spread acceptance of digital health solutions. Technological progress in smart inhalers, the application of big data analytics, the implementation of chip-on-sensors, and enhancing sensor technology are major trends expected to shape the market in the forecast period.
Which Drivers Are Accelerating Growth In The Smart Inhalers Market?
The smart inhaler market's expected expansion is linked to the growing prominence of chronic respiratory diseases (CRDs). This group of long-lasting diseases impacts the lungs' airways and surrounding structures. Smart inhalers play a crucial role in CRD management by maintaining a record of inhaler use and issuing reminders for those who fail to take their medication, guaranteeing steady medication use for symptom management and prevention of flare-ups. In the 2022 National Health Survey by the Australian Bureau of Statistics, it was reported that around 8.5 million Australians, roughly 34% of the population, live with chronic respiratory conditions. Out of these, around 2.8 million people (11%) are battling asthma, an illness typified by wheezing and shortness of breath stemming from airway inflammation. Around 638,000 individuals (2.5%) are believed to carry chronic obstructive pulmonary disease (COPD), a disease typified by continuous airflow limitation leading to major breathing issues. Both these illnesses create significant health challenges, affecting normal functioning and overall quality of life. Therefore, the escalating prevalence of CRDs is contributing to the upward trajectory of the smart inhaler market.
What Are The Core Segments Of The Global Smart Inhalers Market?
The smart inhalers market covered in this report is segmented –
1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Hospitals, Homecare Settings, Other End-Users
Subsegments:
1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): Conventional MDIs, Smart MDIs With Connectivity Features
Pre-Book The Smart Inhalers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Smart Inhalers Market?
Leading businesses in the smart inhaler market are innovating with the creation of sophisticated technologies like digital respiratory health solutions, with the goal of serving a wider consumer base, boosting sales, and increasing profits. Digital respiratory health solutions are technically engineered applications or platforms constructed to tackle and manage lung health conditions digitally. For instance, in February 2022, US-based pharmaceutical services firm, Aptar Pharma, introduced the HeroTracker Sense, a unique digital respiratory health solution and auxiliary connected device developed to convert regular metered-dose inhalers (MDIs) to smart connected health devices. This device, particularly made for globally spread patients battling with persistent respiratory ailments such as asthma, COPD, cystic fibrosis, and conditions related to COVID-19, aims to improve their quality of life. HeroTracker Sense, which attaches to an MDI's canister, boasts advanced functionalities like sensors that monitor inhalation timing, flow speed, and duration. It provides data through a correlated app, featuring date and time stamps for medication reminders and environmental alerts like temperature and humidity. The device is designed to improve patient compliance to prescribed treatments by promoting well-informed and compliant medication usage.
Who Are the Key Players In The Smart Inhalers Market?
Major companies operating in the smart inhalers market are:
• Novartis AG
• AstraZeneca Plc
• GlaxoSmithKline Plc.
• 3M Health Care Limited
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Berry Global Group Inc.
• Aptar Group Inc.
• Lupin Limited
• Findair Sp.Z.o.o.
• OPKO Health Inc.
• Nemera France SAS
• Vectura Group Limited
• Propeller Health
• Inspiro Medical Ltd.
• Biocorp Production
• Cohero Health Inc.
• Pneuma Respiratory Inc.
• Amiko Digital Health Limited
• Cognita Labs LLC
• AireHealth Inc.
• Adherium Ltd.
• Zeolr Technologies Pvt Ltd.
• H&T Presspart Manufacturing Ltd.
What Are The Regional Insights Into The Smart Inhalers Market?
North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
